Enanta Pharmaceuticals, Inc.ENTANASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
29.86%
↑ 218% above average
Average (9y)
-25.40%
Historical baseline
Range
High:258.85%
Low:-213.34%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2025 | 29.86% |
| 2024 | 11.31% |
| 2023 | -10.79% |
| 2022 | -13.02% |
| 2021 | -163.15% |
| 2020 | -213.34% |
| 2019 | -58.41% |
| 2018 | 258.85% |
| 2017 | -20.19% |
| 2016 | -75.16% |